What Is Driving the Shift in Ironwood Pharmaceuticals' Fair Value Story? Ironwood Pharmaceuticals has seen its analyst fair value estimate move from about US$2.50 to roughly US$4.85 per share, a ...
Colgate-Palmolive (CL): recent performance and business profile Colgate-Palmolive (CL) has drawn fresh attention after a strong recent run in its share price, prompting investors to reassess how the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果